,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny-04']
want to know more about destiny-04? is on the case! #asco22 #obroncology 
Executive Managing Editor of #OBROncology (https://t.co/XW1VL90pYg) and #PatientPower (https://t.co/WHsQe8gmv5) at Remedy Health Media. Opinions are mine.